Home
Conditions
Acute Myeloid Leukemia (AML)

Clinical trial condition

Acute Myeloid Leukemia (AML)

Explore clinical trials studying Acute Myeloid Leukemia (AML). Study availability and eligibility vary by location and protocol.

154 public trials 46 recruiting studies

Refine in advanced search Browse all conditions

Acute Myeloid Leukemia (AML) trial results

Not yet recruiting

Harmonized Clinical and Biological Database for Integrated Research Into the Management of Pediatric Acute Myeloid Leukemia

NCT07150676

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Not specified

View Trial Details

Not yet recruiting

Ex Vivo T-Cell-Depleted Haploidentical Transplantation Bridging With Chimeric Antigen Receptor T-cell Therapy and Prophylactic Memory T Cell Infusion for Acute Leukemia

NCT07087847

Conditions: ALL (Acute B-Lymphoblastic Leukemia), Acute Leukemia, Acute Leukemia Refractory, +9 more
Locations: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Azacitidine Combined with Donor Lymphocyte Infusion for Acute Myeloid Leukemia Post-transplant Relapse Prevention.

NCT06754540

Conditions: Acute Myeloid Leukemia (AML), Disease Attributes, Hematologic Diseases, +10 more
Locations: Not specified

View Trial Details

Not yet recruiting

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

NCT06702098

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Guangzhou Ruixin Biotechnology Co., Ltd Guangzhou, Guangdong Province, China, China

View Trial Details

Not yet recruiting

Molecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid Leukemia

NCT06652685

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Ruijin Hospital, Shanghai Jiaotong University School of Medicine Shanghai, China

View Trial Details

Enrolling by invitation

Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure

NCT07813390

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China

View Trial Details

Enrolling by invitation

A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies

NCT07784309

Conditions: Acute Myeloid Leukemia (AML), Acute T Cell Lymphoblastic Leukemia, Hematologic Diseases, +18 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, China

View Trial Details

Enrolling by invitation

Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

NCT07651163

Conditions: Acute Myeloid Leukemia (AML), Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Active, not recruiting

TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies

NCT03849651

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Bone Marrow Diseases, +33 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Active, not recruiting

A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia

NCT05520567

Conditions: Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, +6 more
Locations: City of Hope Nat'l Medical Center Duarte, California, United States

Univ. of California - Irvine Irvine, California, United States

UCLA Medical Center Los Angeles, California, United States

Sarah Cannon Research Institute Denver, Colorado, United States

View all 18 locations

View Trial Details

Acute Myeloid Leukemia (AML)

Acute Myeloid Leukemia (AML) trial results

Related conditions